Frontier Capital Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.01M | Sell |
28,842
-14,419
| -33% | -$1.51M | 0.03% | 281 |
|
|
2025
Q1 | $5.05M | Sell |
43,261
-9,507
| -18% | -$1.11M | 0.06% | 254 |
|
|
2024
Q4 | $4.46M | Sell |
52,768
-67,772
| -56% | -$5.73M | 0.04% | 258 |
|
|
2024
Q3 | $10.8M | Buy |
120,540
+24,513
| +26% | +$2.2M | 0.1% | 209 |
|
|
2024
Q2 | $7.73M | Sell |
96,027
-9,317
| -9% | -$750K | 0.08% | 228 |
|
|
2024
Q1 | $8.41M | Buy |
105,344
+10,456
| +11% | +$834K | 0.08% | 225 |
|
|
2023
Q4 | $7.55M | Sell |
94,888
-65,788
| -41% | -$5.24M | 0.08% | 214 |
|
|
2023
Q3 | $11.2M | Sell |
160,676
-61,544
| -28% | -$4.3M | 0.12% | 183 |
|
|
2023
Q2 | $16M | Buy |
222,220
+181,515
| +446% | +$13M | 0.15% | 168 |
|
|
2023
Q1 | $2.51M | Sell |
40,705
-48,706
| -54% | -$3M | 0.03% | 247 |
|
|
2022
Q4 | $6.9M | Buy |
+89,411
| New | +$6.9M | 0.08% | 215 |
|